Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ignacio F Mata

Showing results (21-30 of 128) with videos related to

Pageof 13
Sort By:
Journal of Parkinson'S Disease|May 20, 2026
The Global Parkinson's Genetics Program (GP2): Advancing genetic discovery and capacity building worldwideVictor Flores-Ocampo, Alexandra Zirra, Yi Wen Tay, et al.
Parkinsonism & Related Disorders|January 10, 2006
Genetics of restless legs syndromeIgnacio F Mata, Cynthia L Bodkin, Charles H Adler, et al.
Arquivos De Neuro-Psiquiatria|May 20, 2025
Levodopa-induced dyskinesia is still a major clinical problem in Brazilian movement disorder clinicsVitor Tumas, Manuelina Mariana Capellari Macruz Brito, Vanderci Borges, et al.
Neuroscience Letters|May 3, 2005
Homozygous partial genomic triplication of the parkin gene in early-onset parkinsonismIgnacio F Mata, Victoria Alvarez, Eliecer Coto, et al.
Neuroscience Letters|February 6, 2014
Clinical and molecular studies reveal a PSEN1 mutation (L153V) in a Peruvian family with early-onset Alzheimer's diseaseMario R Cornejo-Olivas, Chang-En Yu, Pilar Mazzetti, et al.
JAMA Neurology|April 17, 2013
C9orf72 hexanucleotide repeat expansion and Guam amyotrophic lateral sclerosis-Parkinsonism-dementia complexBeth A Dombroski, Douglas R Galasko, Ignacio F Mata, et al.
Brain Communications|September 22, 2025
Polygenic scores contribution to Parkinson's disease comorbiditiesCarlos F Hernández, Camilo Villaman, Cristian Tejos, et al.
Parkinsonism & Related Disorders|November 17, 2024
Critical evaluation of the current landscape of pharmacogenomics in Parkinson's disease - What is missing? A systematic reviewHenry Mauricio Chaparro-Solano, Maria Rivera Paz, Saar Anis, et al.
Neuroscience Letters|October 19, 2004
Chemokines (RANTES and MCP-1) and chemokine-receptors (CCR2 and CCR5) gene polymorphisms in Alzheimer's and Parkinson's diseaseCecilia Huerta, Victoria Alvarez, Ignacio F Mata, et al.
Medrxiv : the Preprint Server for Health Sciences|August 6, 2025
Genome-wide association analyses reveal susceptibility variants linked to Parkinson's disease in the South African population using inferred global and local ancestryKathryn Step, Thiago Peixoto Leal, Emily Waldo, et al.
Pageof 13

Showing results (21-30 of 128) with videos related to

Sort By:
Pageof 13
Journal of Parkinson'S Disease|May 20, 2026
The Global Parkinson's Genetics Program (GP2): Advancing genetic discovery and capacity building worldwideVictor Flores-Ocampo, Alexandra Zirra, Yi Wen Tay, et al.
Parkinsonism & Related Disorders|January 10, 2006
Genetics of restless legs syndromeIgnacio F Mata, Cynthia L Bodkin, Charles H Adler, et al.
Arquivos De Neuro-Psiquiatria|May 20, 2025
Levodopa-induced dyskinesia is still a major clinical problem in Brazilian movement disorder clinicsVitor Tumas, Manuelina Mariana Capellari Macruz Brito, Vanderci Borges, et al.
Neuroscience Letters|May 3, 2005
Homozygous partial genomic triplication of the parkin gene in early-onset parkinsonismIgnacio F Mata, Victoria Alvarez, Eliecer Coto, et al.
Neuroscience Letters|February 6, 2014
Clinical and molecular studies reveal a PSEN1 mutation (L153V) in a Peruvian family with early-onset Alzheimer's diseaseMario R Cornejo-Olivas, Chang-En Yu, Pilar Mazzetti, et al.
JAMA Neurology|April 17, 2013
C9orf72 hexanucleotide repeat expansion and Guam amyotrophic lateral sclerosis-Parkinsonism-dementia complexBeth A Dombroski, Douglas R Galasko, Ignacio F Mata, et al.
Brain Communications|September 22, 2025
Polygenic scores contribution to Parkinson's disease comorbiditiesCarlos F Hernández, Camilo Villaman, Cristian Tejos, et al.
Parkinsonism & Related Disorders|November 17, 2024
Critical evaluation of the current landscape of pharmacogenomics in Parkinson's disease - What is missing? A systematic reviewHenry Mauricio Chaparro-Solano, Maria Rivera Paz, Saar Anis, et al.
Neuroscience Letters|October 19, 2004
Chemokines (RANTES and MCP-1) and chemokine-receptors (CCR2 and CCR5) gene polymorphisms in Alzheimer's and Parkinson's diseaseCecilia Huerta, Victoria Alvarez, Ignacio F Mata, et al.
Medrxiv : the Preprint Server for Health Sciences|August 6, 2025
Genome-wide association analyses reveal susceptibility variants linked to Parkinson's disease in the South African population using inferred global and local ancestryKathryn Step, Thiago Peixoto Leal, Emily Waldo, et al.
Pageof 13